{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:19:07Z","timestamp":1790842747332,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:00:00Z","timestamp":1561766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:00:00Z","timestamp":1561766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["304716\/2014-6"],"award-info":[{"award-number":["304716\/2014-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"crossref","award":["E_032017"],"award-info":[{"award-number":["E_032017"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10863-019-09802-x","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T20:23:21Z","timestamp":1561839801000},"page":"277-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8218-834X","authenticated-orcid":false,"given":"Robson Xavier","family":"Faria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"de Jesus Hiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Pimenta","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson Antonio Lamounier Camargos","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Tosta","family":"Diogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Lidmar","family":"von Ranke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murilo Lamim","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Rangel","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Carla","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"de Luna Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,29]]},"reference":[{"key":"9802_CR1","doi-asserted-by":"publisher","first-page":"8564","DOI":"10.1016\/j.bmc.2006.08.033","volume":"14","author":"V Ahmed","year":"2006","unstructured":"Ahmed V, Liu Y, Silvestro C, Taylor SD (2006) Boronic acids as inhibitors of steroid sulfatase. Bioorg Med Chem 14:8564\u20138573. \n                    https:\/\/doi.org\/10.1016\/j.bmc.2006.08.033","journal-title":"Bioorg Med Chem"},{"key":"9802_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41598-017-00732-5","volume":"7","author":"RC Allsopp","year":"2017","unstructured":"Allsopp RC, Dayl S, Schmid R, Evans RJ (2017) Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120. Sci Rep 7:725","journal-title":"Sci Rep"},{"key":"9802_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/cbic.200300748","volume":"5","author":"T Asano","year":"2004","unstructured":"Asano T, Nakamura H, Uehara Y, Yamamoto Y (2004) Design, synthesis, and biological evaluation of aminoboronic acids as growth-factor receptor inhibitors of EGFR and VEGFR-1 tyrosine kinases. Chembiochem Eur J Chem Biol 5:483\u2013490. \n                    https:\/\/doi.org\/10.1002\/cbic.200300748","journal-title":"Chembiochem Eur J Chem Biol"},{"key":"9802_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/scibx.2012.512","volume":"5","author":"T Baas","year":"2012","unstructured":"Baas T (2012) Paradoxical P2X7. Sci-Bus Exch 5:512\u2013512. \n                    https:\/\/doi.org\/10.1038\/scibx.2012.512","journal-title":"Sci-Bus Exch"},{"key":"9802_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.4155\/fmc.09.71","volume":"1","author":"SJ Baker","year":"2009","unstructured":"Baker SJ, Ding CZ, Akama T, Zhang Y-K, Hernandez V, Xia Y (2009) Therapeutic potential of boron-containing compounds. Future Med Chem 1:1275\u20131288. \n                    https:\/\/doi.org\/10.4155\/fmc.09.71","journal-title":"Future Med Chem"},{"key":"9802_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/tcr.201402100","volume":"15","author":"HS Ban","year":"2015","unstructured":"Ban HS, Nakamura H (2015) Boron-based drug design. Chem Rec N Y N 15:616\u2013635. \n                    https:\/\/doi.org\/10.1002\/tcr.201402100","journal-title":"Chem Rec N Y N"},{"key":"9802_CR7","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1039\/b909504g","volume":"7","author":"HS Ban","year":"2009","unstructured":"Ban HS, Usui T, Nabeyama W, Morita H, Fukuzawa K, Nakamura H (2009) Discovery of boron-conjugated 4-anilinoquinazoline as a prolonged inhibitor of EGFR tyrosine kinase. Org Biomol Chem 7:4415\u20134427. \n                    https:\/\/doi.org\/10.1039\/b909504g","journal-title":"Org Biomol Chem"},{"key":"9802_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1124\/pr.113.008003","volume":"66","author":"R Bartlett","year":"2014","unstructured":"Bartlett R, Stokes L, Sluyter R (2014) The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev 66:638\u2013675. \n                    https:\/\/doi.org\/10.1124\/pr.113.008003","journal-title":"Pharmacol Rev"},{"key":"9802_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2174\/0929867322666141212120926","volume":"22","author":"D Baudelet","year":"2015","unstructured":"Baudelet D, Lipka E, Millet R, Ghinet A (2015) Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential. Curr Med Chem 22:713\u2013729","journal-title":"Curr Med Chem"},{"key":"9802_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1039\/C4QI00032C","volume":"1","author":"B Bhattacharya","year":"2014","unstructured":"Bhattacharya B, Maity DK, Pachfule P, Colacio E, Ghoshal D (2014) Syntheses, X-ray structures, catalytic activity and magnetic properties of two new coordination polymers of Co(II) and Ni(II) based on benzenedicarboxylate and linear N,N\u2032-donor Schiff base linkers. Inorg Chem Front 1:414\u2013425. \n                    https:\/\/doi.org\/10.1039\/c4qi00032c","journal-title":"Inorg Chem Front"},{"key":"9802_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4161\/cam.2.3.6484","volume":"2","author":"TM Bradke","year":"2008","unstructured":"Bradke TM, Hall C, Carper SW, Plopper GE (2008) Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability. Cell Adhes Migr 2:153\u2013160","journal-title":"Cell Adhes Migr"},{"key":"9802_CR12","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.2174\/1381612811319220012","volume":"19","author":"D Buac","year":"2013","unstructured":"Buac D, Shen M, Schmitt S, Kona FR, Deshmukh R, Zhang Z, Neslund-Dudas C, Mitra B, Dou QP (2013) From bortezomib to other inhibitors of the proteasome and beyond. Curr Pharm Des 19:4025\u20134038","journal-title":"Curr Pharm Des"},{"key":"9802_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11302-017-9593-0","volume":"14","author":"G Burnstock","year":"2018","unstructured":"Burnstock G, Knight GE (2018) The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression. Purinergic Signal 14:1\u201318. \n                    https:\/\/doi.org\/10.1007\/s11302-017-9593-0","journal-title":"Purinergic Signal"},{"key":"9802_CR14","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1021\/jo00200a036","volume":"49","author":"JA Cabello","year":"1984","unstructured":"Cabello JA, Campelo JM, Garcia A, Luna D, Marinas JM (1984) Knoevenagel condensation in the heterogeneous phase using aluminum phosphate-aluminum oxide as a new catalyst. J Org Chem 49:5195\u20135197. \n                    https:\/\/doi.org\/10.1021\/jo00200a036","journal-title":"J Org Chem"},{"key":"9802_CR15","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1016\/j.polymer.2011.07.057","volume":"52","author":"JN Cambre","year":"2011","unstructured":"Cambre JN, Sumerlin BS (2011) Biomedical applications of boronic acid polymers. Polymer 52:4631\u20134643. \n                    https:\/\/doi.org\/10.1016\/j.polymer.2011.07.057","journal-title":"Polymer"},{"issue":"15","key":"9802_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bcp.2016.07.020","volume":"116","author":"EA Caseleya","year":"2016","unstructured":"Caseleya EA, Muencha SP, Fishwickb CW, Jiang L (2016) Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists. Biochem Pharmacol 116(15):130\u2013139","journal-title":"Biochem Pharmacol"},{"key":"9802_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cca.2018.01.032","volume":"479","author":"Z Chen","year":"2018","unstructured":"Chen Z, He L, Li L, Chen L (2018) The P2X7 purinergic receptor: an emerging therapeutic target in cardiovascular diseases. Clin Chim Acta Int J Clin Chem 479:196\u2013207. \n                    https:\/\/doi.org\/10.1016\/j.cca.2018.01.032","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"9802_CR18","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ci300367a","volume":"52","author":"F Cheng","year":"2012","unstructured":"Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW, Tang Y (2012) admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 52:3099\u20133105. \n                    https:\/\/doi.org\/10.1021\/ci300367a","journal-title":"J Chem Inf Model"},{"key":"9802_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4155\/fmc.13.38","volume":"5","author":"BC Das","year":"2013","unstructured":"Das BC, Thapa P, Karki R, Schinke C, Das S, Kambhampati S, Banerjee SK, Van Veldhuizen P, Verma A, Weiss LM, Evans T (2013) Boron chemicals in diagnosis and therapeutics. Future Med Chem 5:653\u2013676. \n                    https:\/\/doi.org\/10.4155\/fmc.13.38","journal-title":"Future Med Chem"},{"key":"9802_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10562-016-1916-1","volume":"147","author":"JBM de Resende Filho","year":"2017","unstructured":"de Resende Filho JBM, Pires GP, de Oliveira Ferreira JMG, Teotonio EES, Vale JA (2017) Knoevenagel condensation of aldehydes and ketones with Malononitrile catalyzed by amine compounds-tethered Fe3O4@SiO2 nanoparticles. Catal Lett 147:167\u2013180. \n                    https:\/\/doi.org\/10.1007\/s10562-016-1916-1","journal-title":"Catal Lett"},{"key":"9802_CR21","unstructured":"Deb, M.L., Bhuyan, P.J., 2005. Uncatalysed Knoevenagel condensation in aqueous medium at room temperature - PDF free download [WWW document]. Tetrahedron Lett. URL \n                    https:\/\/www.sciencedirect.com\/science\/article\/pii\/S004040390501631X\n                    \n                   (accessed 9.20.18)"},{"key":"9802_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nchem.2814","volume":"9","author":"DB Diaz","year":"2017","unstructured":"Diaz DB, Yudin AK (2017) The versatility of boron in biological target engagement. Nat Chem 9:731\u2013742. \n                    https:\/\/doi.org\/10.1038\/nchem.2814","journal-title":"Nat Chem"},{"key":"9802_CR23","doi-asserted-by":"publisher","unstructured":"Dimitrova P, Ivanovska N (2013) Tyrphostins as a promising therapeutic tool in inflammation-related conditions. OA Inflamm 1. \n                    https:\/\/doi.org\/10.13172\/2052-787X-1-1-608","DOI":"10.13172\/2052-787X-1-1-608"},{"key":"9802_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neuropharm.2008.06.012","volume":"56","author":"DL Donnelly-Roberts","year":"2009","unstructured":"Donnelly-Roberts DL, Namovic MT, Surber B, Vaidyanathan SX, Perez-Medrano A, Wang Y, Carroll WA, Jarvis MF (2009) [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors. Neuropharm. 56:223\u2013229","journal-title":"Neuropharm."},{"key":"9802_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/1568009614666140804154511","volume":"14","author":"QP Dou","year":"2014","unstructured":"Dou QP, Zonder JA (2014) Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system. Curr. Cancer Drug Targets 14:517\u2013536","journal-title":"Cancer Drug Targets"},{"key":"9802_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10863-017-9717-9","volume":"49","author":"RX Faria","year":"2017","unstructured":"Faria RX, Freitas HR, Reis RAM (2017) P2X7 receptor large pore signaling in avian M\u00fcller glial cells. J Bioenerg Biomembr 49:215\u2013229. \n                    https:\/\/doi.org\/10.1007\/s10863-017-9717-9","journal-title":"J Bioenerg Biomembr"},{"key":"9802_CR27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.ejmech.2017.10.033","volume":"143","author":"RX Faria","year":"2018","unstructured":"Faria RX, Oliveira FH, Salles JP, Oliveira AS, von Ranke NL, Bello ML, Rodrigues CR, Castro HC, Louvis AR, Martins DL, Ferreira VF (2018) 1,4-naphthoquinones potently inhibiting P2X7 receptor activity. Eur J Med Chem 143:1361\u20131372. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.033","journal-title":"Eur J Med Chem"},{"key":"9802_CR28","doi-asserted-by":"publisher","first-page":"7902","DOI":"10.1021\/jm100762r","volume":"53","author":"FF Fleming","year":"2010","unstructured":"Fleming FF, Yao L, Ravikumar PC, Funk L, Shook BC (2010) Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore. J Med Chem 53:7902\u20137917. \n                    https:\/\/doi.org\/10.1021\/jm100762r","journal-title":"J Med Chem"},{"key":"9802_CR29","doi-asserted-by":"publisher","unstructured":"Gonzaga DTG, Gomes LB, Costa TEMC, von Ranke NL, Pacheco PAF, Sim\u00f5es APS, Arruda JC, Dantas LP, de Freiras HR, Reis RA, Penido C, Bello ML, Castro HC, Rodrigues CRR, Ferreira VF, Faria RX, Silva FC (2017) 1-Aryl-1H- and 2-aryl-2H-1,2,3-triazole derivatives blockade P2X7 receptor in vitro and inflammatory response in vivo. Eur J Med Chem 139:698\u2013717. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2017.08.034","DOI":"10.1016\/j.ejmech.2017.08.034"},{"key":"9802_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/wmts.33","volume":"1","author":"GI Gorodeski","year":"2012","unstructured":"Gorodeski GI (2012) P2X7 receptors and epithelial cancers. Wiley Interdiscip Rev Membr Transp Signal 1:349\u2013371. \n                    https:\/\/doi.org\/10.1002\/wmts.33","journal-title":"Wiley Interdiscip Rev Membr Transp Signal"},{"key":"9802_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00045391-200109000-00005","volume":"8","author":"MP Groziak","year":"2001","unstructured":"Groziak MP (2001) Boron therapeutics on the horizon. Am J Ther 8:321\u2013328","journal-title":"Am J Ther"},{"key":"9802_CR32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10753-014-9820-6","volume":"37","author":"V Gyurkovska","year":"2014","unstructured":"Gyurkovska V, Stefanova T, Dimitrova P, Danova S, Tropcheva R, Ivanovska N (2014) Tyrosine kinase inhibitor tyrphostin AG490 retards chronic joint inflammation in mice. Inflammation 37:995\u20131005. \n                    https:\/\/doi.org\/10.1007\/s10753-014-9820-6","journal-title":"Inflammation"},{"key":"9802_CR33","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17:490\u2013519. \n                    https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","journal-title":"J Comput Chem"},{"key":"9802_CR34","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/cmdc.201800206","volume":"13","author":"N d J Hiller","year":"2018","unstructured":"Hiller N d J, Silva NAAE, Faria RX, Souza ALA, Resende JALC, Borges Farias A, Correia Romeiro N, de Luna Martins D (2018) Synthesis and evaluation of the anticancer and Trypanocidal activities of Boronic Tyrphostins. ChemMedChem 13:1395\u20131404. \n                    https:\/\/doi.org\/10.1002\/cmdc.201800206","journal-title":"ChemMedChem"},{"key":"9802_CR35","doi-asserted-by":"crossref","unstructured":"Humphreys, B.D., Virginio, C., Surprenant, A., Rice, J., Dubyak, G.R., 1998. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol Pharmacol. Jul;54(1):22-32","DOI":"10.1124\/mol.54.1.22"},{"key":"9802_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1124\/mol.58.1.82","volume":"58","author":"LH Jiang","year":"2000","unstructured":"Jiang LH, MacKenzie AB, North RA, Surprenant A (2000) BBG selectively blocks ATP-gated rat P2X7 receptors. Mol Pharmacol 58:82\u201388","journal-title":"Mol Pharmacol"},{"key":"9802_CR37","doi-asserted-by":"publisher","unstructured":"Karasawa A, Kawate T (2016) Structural basis for subtype-specific inhibition of the P2X7 receptor. eLife 5. \n                    https:\/\/doi.org\/10.7554\/eLife.22153","DOI":"10.7554\/eLife.22153"},{"key":"9802_CR38","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1093\/emboj\/20.22.6347","volume":"20","author":"M Kim","year":"2001","unstructured":"Kim M, Jiang LH, Wilson HL, North RA, Surprenant A (2001) Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J 20:6347\u20136358. \n                    https:\/\/doi.org\/10.1093\/emboj\/20.22.6347","journal-title":"EMBO J"},{"key":"9802_CR39","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1021\/bi00789a008","volume":"10","author":"KA Koehler","year":"1971","unstructured":"Koehler KA, Lienhard GE (1971) 2-phenylethaneboronic acid, a possible transition-state analog for chymotrypsin. Biochemistry 10:2477\u20132483","journal-title":"Biochemistry"},{"key":"9802_CR40","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1021\/jm030213+","volume":"46","author":"SK Kumar","year":"2003","unstructured":"Kumar SK, Hager E, Pettit C, Gurulingappa H, Davidson NE, Khan SR (2003) Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents. J Med Chem 46:2813\u20132815. \n                    https:\/\/doi.org\/10.1021\/jm030213+","journal-title":"J Med Chem"},{"key":"9802_CR41","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ejmech.2018.03.023","volume":"151","author":"SH Kwak","year":"2018","unstructured":"Kwak SH, Shin S, Lee JH, Shim JK, Kim M, Lee SD, Lee A, Bae J, Park JH, Abdelrahman A, M\u00fcller CE, Cho SK, Kang SG, Bae MA, Yang JY, Ko H, Goddard WA, Kim YC (2018) Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells. Eur J Med Chem 151:462\u2013481","journal-title":"Eur J Med Chem"},{"key":"9802_CR42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/qsar.200860192","volume":"28","author":"A Lagunin","year":"2009","unstructured":"Lagunin A, Filimonov D, Zakharov A, Xie W, Huang Y, Zhu F, Shen T, Yao J, Poroikov V (2009) Computer-aided prediction of rodent carcinogenicity by PASS and CISOC-PSCT. QSAR Comb Sci 28:806\u2013810. \n                    https:\/\/doi.org\/10.1002\/qsar.200860192","journal-title":"QSAR Comb Sci"},{"key":"9802_CR43","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.chembiol.2008.05.020","volume":"15","author":"AM LeBeau","year":"2008","unstructured":"LeBeau AM, Singh P, Isaacs JT, Denmeade SR (2008) Potent and selective peptidyl Boronic acid inhibitors of the serine protease prostate-specific antigen. Chem Biol 15:665\u2013674. \n                    https:\/\/doi.org\/10.1016\/j.chembiol.2008.05.020","journal-title":"Chem Biol"},{"key":"9802_CR44","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1039\/c0gc00877j","volume":"13","author":"G Li","year":"2011","unstructured":"Li G, Xiao J, Zhang W (2011) Knoevenagel condensation catalyzed by a tertiary-amine functionalized polyacrylonitrile fiber. Green Chem 13:1828\u20131836. \n                    https:\/\/doi.org\/10.1039\/C0GC00877J","journal-title":"Green Chem"},{"key":"9802_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/minf.201000159","volume":"30","author":"RL Marchese Robinson","year":"2011","unstructured":"Marchese Robinson RL, Glen RC, Mitchell JBO (2011) Development and comparison of hERG blocker classifiers: assessment on different datasets yields markedly different results. Mol Inform 30:443\u2013458. \n                    https:\/\/doi.org\/10.1002\/minf.201000159","journal-title":"Mol Inform"},{"key":"9802_CR46","first-page":"7120","volume":"250","author":"DA Matthews","year":"1975","unstructured":"Matthews DA, Alden RA, Birktoft JJ, Freer ST, Kraut J (1975) X-ray crystallographic study of boronic acid adducts with subtilisin BPN\u2019 (novo). A model for the catalytic transition state J Biol Chem 250:7120\u20137126","journal-title":"A model for the catalytic transition state J Biol Chem"},{"key":"9802_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bmc.2013.10.054","volume":"22","author":"N Mehta","year":"2014","unstructured":"Mehta N, Kaur M, Singh M, Chand S, Vyas B, Silakari P, Bahia MS, Silakari O (2014) Purinergic receptor P2X7: a novel target for anti-inflammatory therapy. Bioorg Med Chem 22:54\u201388. \n                    https:\/\/doi.org\/10.1016\/j.bmc.2013.10.054","journal-title":"Bioorg Med Chem"},{"key":"9802_CR48","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1016\/j.bmc.2006.01.003","volume":"14","author":"A Modzelewska","year":"2006","unstructured":"Modzelewska A, Pettit C, Achanta G, Davidson NE, Huang P, Khan SR (2006) Anticancer activities of novel chalcone and bis-chalcone derivatives. Bioorg Med Chem 14:3491\u20133495. \n                    https:\/\/doi.org\/10.1016\/j.bmc.2006.01.003","journal-title":"Bioorg Med Chem"},{"key":"9802_CR49","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1080\/00397910802029364","volume":"38","author":"C Mukhopadhyay","year":"2008","unstructured":"Mukhopadhyay C, Datta A (2008) A simple, efficient and green procedure for the Knoevenagel condensation of aldehydes with N-Methylpiperazine at room temperature under solvent-free conditions. Synth Commun 38:2103\u20132112. \n                    https:\/\/doi.org\/10.1080\/00397910802029364","journal-title":"Synth Commun"},{"key":"9802_CR50","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/cmdc.200600068","volume":"1","author":"H Nakamura","year":"2006","unstructured":"Nakamura H, Kuroda H, Saito H, Suzuki R, Yamori T, Maruyama K, Haga T (2006) Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerization inhibitors. ChemMedChem 1:729\u2013740. \n                    https:\/\/doi.org\/10.1002\/cmdc.200600068","journal-title":"ChemMedChem"},{"key":"9802_CR51","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","volume":"82","author":"RA North","year":"2002","unstructured":"North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013\u20131067. \n                    https:\/\/doi.org\/10.1152\/physrev.00015.2002","journal-title":"Physiol Rev"},{"key":"9802_CR52","doi-asserted-by":"crossref","unstructured":"O'Brien-Brown, J., Jackson, A., Reekie, T.A., Barron, M.L., Werry, E.L., Schiavini, P., McDonnell, M., Munoz, L., Wilkinson, S., Noll, B., Wang, S., Kassiou, M., 2017. Discovery and pharmacological evaluation of a novel series of adamantyl cyanoguanidines as P2X7 receptor antagonists. Eur J med Chem. Apr 21;130:433-439","DOI":"10.1016\/j.ejmech.2017.02.060"},{"key":"9802_CR53","doi-asserted-by":"crossref","unstructured":"Pacheco PAF, Galv\u00e3o RMS, Faria AFM, von Ranke, NL, Rangel MS, Ribeiro TM, Bello ML, Rodrigues CF, Ferreira VF, da Rocha DR, Faria RX (2018) 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages. Bioorg Med Chem 27:1449\u20131455","DOI":"10.1016\/j.bmc.2018.11.036"},{"key":"9802_CR54","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/minf.201000118","volume":"30","author":"H Pham The","year":"2011","unstructured":"Pham The H, Gonz\u00e1lez-\u00c1lvarez I, Bermejo M, Mangas Sanjuan V, Centelles I, Garrigues TM, Cabrera-P\u00e9rez M\u00c1 (2011) In silico prediction of Caco-2 cell permeability by a classification QSAR approach. Mol. Inform. 30:376\u2013385. \n                    https:\/\/doi.org\/10.1002\/minf.201000118","journal-title":"Mol. Inform."},{"key":"9802_CR55","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1073\/pnas.68.2.478","volume":"68","author":"M Philipp","year":"1971","unstructured":"Philipp M, Bender ML (1971) Inhibition of serine proteases by arylboronic acids. Proc Natl Acad Sci U S A 68:478\u2013480","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9802_CR56","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1016\/j.bmcl.2016.06.048","volume":"26","author":"JC Rech","year":"2016","unstructured":"Rech JC, Bhattacharya A, Letavic MA, Savall BM (2016) The evolution of P2X7 antagonists with a focus on CNS indications. Bioorg Med Chem Lett 26:3838\u20133845. \n                    https:\/\/doi.org\/10.1016\/j.bmcl.2016.06.048","journal-title":"Bioorg Med Chem Lett"},{"key":"9802_CR57","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1080\/00397910701397375","volume":"37","author":"Y Ren","year":"2007","unstructured":"Ren Y, Cai C (2007) Knoevenagel condensation of aromatic aldehydes with active methylene compounds using a catalytic amount of iodine and K 2 CO 3 at room temperature. Synth Commun 37:2209\u20132213. \n                    https:\/\/doi.org\/10.1080\/00397910701397375","journal-title":"Synth Commun"},{"key":"9802_CR58","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/jcc.20425","volume":"27","author":"GB Rocha","year":"2006","unstructured":"Rocha GB, Freire RO, Simas AM, Stewart JJP (2006) RM1: a reparameterization of AM1 for H, C, N, O, P, S, F, cl, Br, and I. J Comput Chem 27:1101\u20131111. \n                    https:\/\/doi.org\/10.1002\/jcc.20425","journal-title":"J Comput Chem"},{"key":"9802_CR59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fphar.2018.00052","volume":"9","author":"LEB Savio","year":"2018","unstructured":"Savio LEB, de Andrade Mello P, da Silva CG, Coutinho-Silva R (2018) The P2X7 receptor in inflammatory diseases: angel or demon? Front Pharmacol 9:52. \n                    https:\/\/doi.org\/10.3389\/fphar.2018.00052","journal-title":"Front Pharmacol"},{"key":"9802_CR60","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1074\/jbc.M507816200","volume":"281","author":"AN Shemon","year":"2006","unstructured":"Shemon AN, Sluyter R, Fernando SL, Clarke AL, Dao-Ung L-P, Skarratt KK, Saunders BM, Tan KS, Gu BJ, Fuller SJ, Britton WJ, Petrou S, Wiley JS (2006) A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 281:2079\u20132086. \n                    https:\/\/doi.org\/10.1074\/jbc.M507816200","journal-title":"J Biol Chem"},{"key":"9802_CR61","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1021\/ci100104j","volume":"50","author":"J Shen","year":"2010","unstructured":"Shen J, Cheng F, Xu Y, Li W, Tang Y (2010) Estimation of ADME properties with substructure pattern recognition. J Chem Inf Model 50:1034\u20131041. \n                    https:\/\/doi.org\/10.1021\/ci100104j","journal-title":"J Chem Inf Model"},{"key":"9802_CR62","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.bmcl.2009.12.037","volume":"20","author":"K Shimizu","year":"2010","unstructured":"Shimizu K, Maruyama M, Yasui Y, Minegishi H, Ban HS, Nakamura H (2010) Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1alpha inhibitors. Bioorg Med Chem Lett 20:1453\u20131456. \n                    https:\/\/doi.org\/10.1016\/j.bmcl.2009.12.037","journal-title":"Bioorg Med Chem Lett"},{"key":"9802_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/187152711794488638","volume":"10","author":"SD Skaper","year":"2011","unstructured":"Skaper SD (2011) Ion channels on microglia: therapeutic targets for neuroprotection. CNS Neurol. Disord. Drug Targets 10:44\u201356","journal-title":"Drug Targets"},{"key":"9802_CR64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/recl.19961150109","volume":"115","author":"H Suenaga","year":"1996","unstructured":"Suenaga H, Nakashima K, Mikami M, Yamamoto H, James TD, Sandanayake KRAS, Shinkai S (1996) Screening of arylboronic acids to search for a strong inhibitor for \u03b3-glutamyl transpeptidase (\u03b3-GTP). Recl Trav Chim Pays-Bas-J R Neth 115:44\u201348","journal-title":"Recl Trav Chim Pays-Bas-J R Neth"},{"key":"9802_CR65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4239\/wjd.v5.i2.141","volume":"5","author":"T Sugiyama","year":"2014","unstructured":"Sugiyama T (2014) Role of P2X7 receptors in the development of diabetic retinopathy. World J Diabetes 5:141\u2013145. \n                    https:\/\/doi.org\/10.4239\/wjd.v5.i2.141","journal-title":"World J Diabetes"},{"key":"9802_CR66","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/ci300046g","volume":"52","author":"M Swain","year":"2012","unstructured":"Swain M (2012) Chemicalize.Orgchemicalize.Orgby ChemAxon ltd. J Chem Inf Model 52:613\u2013615. \n                    https:\/\/doi.org\/10.1021\/ci300046g","journal-title":"J Chem Inf Model"},{"key":"9802_CR67","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1021\/jm051197e","volume":"49","author":"R Thomsen","year":"2006","unstructured":"Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49:3315\u20133321. \n                    https:\/\/doi.org\/10.1021\/jm051197e","journal-title":"J Med Chem"},{"key":"9802_CR68","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.brainresrev.2009.11.003","volume":"63","author":"M Tsuda","year":"2010","unstructured":"Tsuda M, Tozaki-Saitoh H, Inoue K (2010) Pain and purinergic signaling. Brain Res Rev 63:222\u2013232. \n                    https:\/\/doi.org\/10.1016\/j.brainresrev.2009.11.003","journal-title":"Brain Res Rev"},{"key":"9802_CR69","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2174\/187152712803581137","volume":"11","author":"C Volont\u00e9","year":"2012","unstructured":"Volont\u00e9 C, Apolloni S, Skaper SD, Burnstock G (2012) P2X7 receptors: channels, pores and more. CNS Neurol. Disord. Drug Targets 11:705\u2013721","journal-title":"Drug Targets"},{"key":"9802_CR70","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1081\/SCC-100103255","volume":"31","author":"S Wang","year":"2001","unstructured":"Wang S, Ren Z, Cao W, Tong W (2001) The Knoevenagel condensation of aromatic aldehydes with Malononitrile or ethyl Cyanoacetate in the presence of Ctmab in water. Synth Commun 31:673\u2013677. \n                    https:\/\/doi.org\/10.1081\/SCC-100103255","journal-title":"Synth Commun"},{"key":"9802_CR71","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1021\/jm980343w","volume":"41","author":"GS Weston","year":"1998","unstructured":"Weston GS, Bl\u00e1zquez J, Baquero F, Shoichet BK (1998) Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. J Med Chem 41:4577\u20134586. \n                    https:\/\/doi.org\/10.1021\/jm980343w","journal-title":"J Med Chem"},{"key":"9802_CR72","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fchem.2018.00248","volume":"6","author":"CNJ Young","year":"2018","unstructured":"Young CNJ, G\u00f3recki DC (2018) P2RX7 Purinoceptor as a therapeutic target-The second coming? Front Chem 6:248. \n                    https:\/\/doi.org\/10.3389\/fchem.2018.00248","journal-title":"Front Chem"},{"key":"9802_CR73","doi-asserted-by":"publisher","first-page":"12478","DOI":"10.3390\/molecules171112478","volume":"17","author":"A Zervosen","year":"2012","unstructured":"Zervosen A, Sauvage E, Fr\u00e8re J-M, Charlier P, Luxen A (2012) Development of new drugs for an old target: the penicillin binding proteins. Mol Basel Switz 17:12478\u201312505. \n                    https:\/\/doi.org\/10.3390\/molecules171112478","journal-title":"Mol Basel Switz"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-019-09802-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10863-019-09802-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-019-09802-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T23:15:13Z","timestamp":1593299713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10863-019-09802-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,29]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["9802"],"URL":"https:\/\/doi.org\/10.1007\/s10863-019-09802-x","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,29]]},"assertion":[{"value":"14 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}